Yoo Ji Geun, Lee Sung Jong, Nam Eun Ji, No Jae Hong, Park Jeong Yeol, Song Jae Yun, Shin So-Jin, Yun Bo Seong, Park Sung Taek, Lee San-Hui, Suh Dong Hoon, Kim Yong Beom, Lee Keun Ho
Department of Obstetrics and Gynecology, Daejeon St. Mary's Hospital, The Catholic University of Korea, Daejeon, Korea.
Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
J Gynecol Oncol. 2025 Jan;36(1):e70. doi: 10.3802/jgo.2025.36.e70.
We describe the updated Korean Society of Gynecologic Oncology (KSGO) practice guideline for the management of cervical cancer, version 5.1. The KSGO announced the fifth version of its clinical practice guidelines for the management of cervical cancer in March 2024. The selection of the key questions and the systematic reviews were based on data available up to December 2022. Between 2023 and 2024, substantial findings from large-scale clinical trials and new advancements in cervical cancer research remarkably emerged. Therefore, based on the existing version 5.0, we updated the guidelines with newly accumulated clinical data and added 4 new key questions reflecting the latest insights in the field of cervical cancer. For each question, recommendation was formulated with corresponding level of evidence and grade of recommendation, all established through expert consensus.
我们描述了更新后的韩国妇科肿瘤学会(KSGO)宫颈癌管理实践指南,第5.1版。KSGO于2024年3月公布了其宫颈癌管理临床实践指南的第五版。关键问题的选择和系统评价基于截至2022年12月的可用数据。在2023年至2024年期间,大规模临床试验的大量研究结果以及宫颈癌研究的新进展显著出现。因此,基于现有的第5.0版,我们用新积累的临床数据更新了指南,并增加了4个反映宫颈癌领域最新见解的新关键问题。对于每个问题,通过专家共识确定了相应的证据水平和推荐等级来制定推荐意见。